Jennifer Pfeiffer
Papers
1
Total Citations
94
H-Index
1
About
Jennifer Pfeiffer is a pioneering virologist whose research centers on developing innovative vaccine platforms for emerging infectious diseases, with a particular focus on avian influenza and viral vector technologies. Her most impactful contribution is the groundbreaking 2006 study on protective avian influenza vaccination using a non-replicating human adenovirus vector, which has garnered 94 citations and established a foundational approach for in ovo vaccination strategies. This work demonstrated the feasibility of delivering safe, effective immunity directly to developing embryos, offering a scalable solution for poultry protection against highly pathogenic strains. Pfeiffer’s research bridges veterinary and human health, emphasizing cross-species vaccine design and the potential for adenovirus vectors to combat pandemic threats. Her achievements include advancing the understanding of mucosal immunity and vector-based immunoprophylaxis, with implications for both agricultural biosecurity and global health preparedness. By integrating molecular virology with translational vaccine development, Pfeiffer has provided critical tools for mitigating influenza outbreaks, earning recognition as a key contributor to next-generation vaccination strategies. Her work continues to inspire researchers exploring non-replicating viral vectors for rapid, cost-effective immunization.
Research Focus
Key Achievements
Top Papers
- 1